Community
TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
May 14, 2026
2 min read
72

Spire Healthcare's stock surged by 46.78% after the company received a non-binding cash takeover proposal from Toscafund Asset Management. The offer values Spire at 250 pence per share, or approximately £1 billion in total.
The proposal follows a strategic review Spire initiated in September 2025. Spire's board has indicated it would be minded to recommend the offer to shareholders. This development comes after previous takeover discussions with Bridgepoint and Triton ended in March. Alongside the news, Spire reported that trading for the first four months of 2026 was in line with expectations, supported by strong private patient revenue.
The market backdrop was positive, with the FTSE 250 index, where Spire is listed, rising 0.62%. UK equities were further supported by stronger-than-expected Q1 2026 GDP growth of 0.6%. An analyst from Peel Hunt noted that Spire's business is fundamentally improved and sees potential value exceeding the 250p offer.
Spire's board is now in discussions with Toscafund, which is conducting confirmatory due diligence. Shareholders will await a firm intention to make an offer based on the current financial terms.
Q: Why did Spire Healthcare's stock price increase?
A: The stock surged following a non-binding £1 billion takeover proposal from Toscafund Asset Management at 250 pence per share.
Q: What is the company's current trading performance?
A: Spire Healthcare confirmed that trading in the first four months of 2026 has been in line with expectations.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles